Thomas Gasser

Thomas Gasser is Professor of Neurology and Medical Director of the Department of Neurodegenerative Diseases at the Hertie Institute for Clinical Brain Research and the Neurological Clinic of the Center for Neurology at the University of Tübingen. His main areas of research are the genetic and molecular basis of Parkinson’s disease, dystonias and other movement disorders, including the mapping, cloning and functional characterization of Mendelian genes causing Parkinson's disease and other movement disorders, as well as their diagnosis and treatment but also the identification of common genetic variability which contributes to the sporadic forms of the disease. He recently received the 2024 Breakthrough Prize in Life Sciences, together with Dr. Andrew Singleton and Dr. Ellen Sidransky, which honors transformative advances towards understanding living systems and extending human life, for his groundbreaking research into genetic risk factors for Parkinson's disease.